| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | filamin binding | 7.97e-13 | 29 | 52 | 7 | GO:0031005 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 2.26e-11 | 23 | 52 | 6 | GO:0034235 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.93e-10 | 14 | 52 | 5 | GO:0005130 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.94e-10 | 34 | 52 | 6 | GO:0015125 | |
| GeneOntologyMolecularFunction | glycolipid binding | 2.97e-09 | 49 | 52 | 6 | GO:0051861 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.11e-08 | 29 | 52 | 5 | GO:0035325 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.67e-08 | 70 | 52 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 3.45e-08 | 73 | 52 | 6 | GO:0170055 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.13e-07 | 149 | 52 | 7 | GO:1990782 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.22e-07 | 90 | 52 | 6 | GO:0008028 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.11e-06 | 230 | 52 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | high-affinity IgG receptor activity | 6.65e-06 | 2 | 52 | 2 | GO:0019771 | |
| GeneOntologyMolecularFunction | leukotriene receptor binding | 6.65e-06 | 2 | 52 | 2 | GO:0031774 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.16e-05 | 196 | 52 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | protein kinase binding | FOXM1 CEACAM5 CD6 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 TRIM77 PSG8 FAM83H | 1.22e-05 | 873 | 52 | 11 | GO:0019901 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.58e-05 | 207 | 52 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.62e-05 | 208 | 52 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.69e-05 | 316 | 52 | 7 | GO:0035091 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.71e-05 | 210 | 52 | 6 | GO:0019903 | |
| GeneOntologyMolecularFunction | actin binding | 3.08e-05 | 479 | 52 | 8 | GO:0003779 | |
| GeneOntologyMolecularFunction | kinase binding | FOXM1 CEACAM5 CD6 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 TRIM77 PSG8 FAM83H | 3.21e-05 | 969 | 52 | 11 | GO:0019900 |
| GeneOntologyMolecularFunction | phosphatase binding | 6.17e-05 | 264 | 52 | 6 | GO:0019902 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 7.32e-05 | 398 | 52 | 7 | GO:0046982 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 8.61e-05 | 173 | 52 | 5 | GO:0070851 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.10e-04 | 293 | 52 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 1.39e-04 | 7 | 52 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | IgG binding | 3.60e-04 | 11 | 52 | 2 | GO:0019864 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SYNPO2 CEACAM5 LMO7 MYO10 PSG6 PSG9 CEACAM8 APBB1 CEACAM6 PSG8 | 4.67e-04 | 1099 | 52 | 10 | GO:0008092 |
| GeneOntologyMolecularFunction | phospholipid binding | 5.18e-04 | 548 | 52 | 7 | GO:0005543 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 5.93e-04 | 14 | 52 | 2 | GO:0019763 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 9.55e-04 | 1205 | 52 | 10 | GO:0046983 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 1.14e-03 | 815 | 52 | 8 | GO:0042803 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 1.52e-03 | 324 | 52 | 5 | GO:0005126 | |
| GeneOntologyMolecularFunction | lipid binding | 3.79e-03 | 988 | 52 | 8 | GO:0008289 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 3.96e-03 | 36 | 52 | 2 | GO:0019865 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 4.18e-03 | 37 | 52 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | actinin binding | 5.61e-03 | 43 | 52 | 2 | GO:0042805 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 7.82e-03 | 51 | 52 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 9.04e-03 | 55 | 52 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 9.76e-03 | 1160 | 52 | 8 | GO:0030674 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 5.63e-13 | 14 | 52 | 6 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 9.37e-13 | 15 | 52 | 6 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 9.37e-13 | 15 | 52 | 6 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.50e-12 | 16 | 52 | 6 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 2.31e-12 | 17 | 52 | 6 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 2.31e-12 | 17 | 52 | 6 | GO:1901143 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 3.46e-12 | 18 | 52 | 6 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 7.19e-12 | 20 | 52 | 6 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.00e-11 | 21 | 52 | 6 | GO:0070345 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 5.42e-11 | 27 | 52 | 6 | GO:0070344 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.64e-10 | 32 | 52 | 6 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 2.00e-10 | 33 | 52 | 6 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 2.46e-10 | 15 | 52 | 5 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.46e-10 | 15 | 52 | 5 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.93e-10 | 35 | 52 | 6 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 4.95e-10 | 38 | 52 | 6 | GO:2000345 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 5.06e-10 | 17 | 52 | 5 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 5.83e-10 | 39 | 52 | 6 | GO:0045717 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | CEACAM5 FCGR1A FCGR1BP PSG6 PSG9 AAK1 CEACAM8 CEACAM6 TMEM108 PSG8 CUBN | 6.26e-10 | 337 | 52 | 11 | GO:0006898 |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.44e-09 | 45 | 52 | 6 | GO:0048521 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.65e-09 | 21 | 52 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.65e-09 | 21 | 52 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.65e-09 | 46 | 52 | 6 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.65e-09 | 46 | 52 | 6 | GO:0072574 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.89e-09 | 47 | 52 | 6 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 2.13e-09 | 22 | 52 | 5 | GO:0030853 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 2.45e-09 | 49 | 52 | 6 | GO:0072576 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 2.72e-09 | 23 | 52 | 5 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.72e-09 | 23 | 52 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 2.93e-09 | 91 | 52 | 7 | GO:0051055 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 3.43e-09 | 24 | 52 | 5 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 3.43e-09 | 24 | 52 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 3.43e-09 | 24 | 52 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 4.28e-09 | 25 | 52 | 5 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 4.28e-09 | 25 | 52 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 5.96e-09 | 232 | 52 | 9 | GO:0002706 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 7.86e-09 | 28 | 52 | 5 | GO:0034111 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 8.60e-09 | 60 | 52 | 6 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 9.48e-09 | 29 | 52 | 5 | GO:2001212 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 9.52e-09 | 61 | 52 | 6 | GO:0060259 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.35e-08 | 31 | 52 | 5 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.60e-08 | 32 | 52 | 5 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.60e-08 | 32 | 52 | 5 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.88e-08 | 33 | 52 | 5 | GO:0030852 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 2.10e-08 | 187 | 52 | 8 | GO:0001909 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.20e-08 | 34 | 52 | 5 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 2.20e-08 | 34 | 52 | 5 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 2.85e-08 | 73 | 52 | 6 | GO:0042304 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 5.15e-08 | 40 | 52 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 5.85e-08 | 41 | 52 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 6.63e-08 | 42 | 52 | 5 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 7.07e-08 | 309 | 52 | 9 | GO:0002703 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 7.53e-08 | 145 | 52 | 7 | GO:0045833 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 7.68e-08 | 86 | 52 | 6 | GO:0042058 | |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 9.08e-08 | 149 | 52 | 7 | GO:0062014 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.18e-07 | 47 | 52 | 5 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 1.18e-07 | 47 | 52 | 5 | GO:0034104 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 1.23e-07 | 93 | 52 | 6 | GO:1901184 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.47e-07 | 49 | 52 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.63e-07 | 50 | 52 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 1.99e-07 | 52 | 52 | 5 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 2.19e-07 | 53 | 52 | 5 | GO:0034110 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 2.90e-07 | 56 | 52 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 3.05e-07 | 178 | 52 | 7 | GO:0022612 | |
| GeneOntologyBiologicalProcess | cell growth | CEACAM5 PSG6 PSG9 USP9X CEACAM8 CEACAM6 ROBO1 TMEM108 PSG8 DCC RIMS2 | 3.54e-07 | 625 | 52 | 11 | GO:0016049 |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 3.78e-07 | 59 | 52 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 4.11e-07 | 60 | 52 | 5 | GO:0030851 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.26e-07 | 187 | 52 | 7 | GO:0007156 | |
| GeneOntologyBiologicalProcess | regulation of ketone metabolic process | 4.58e-07 | 189 | 52 | 7 | GO:0010565 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 5.07e-07 | 118 | 52 | 6 | GO:0001570 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 6.65e-07 | 66 | 52 | 5 | GO:0010543 | |
| GeneOntologyBiologicalProcess | liver development | 7.17e-07 | 202 | 52 | 7 | GO:0001889 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 7.17e-07 | 67 | 52 | 5 | GO:0045601 | |
| GeneOntologyBiologicalProcess | endocytosis | CEACAM5 FCGR1A FCGR1BP PSG6 PSG9 IGHG3 AAK1 CEACAM8 CEACAM6 TMEM108 PSG8 CUBN | 7.50e-07 | 827 | 52 | 12 | GO:0006897 |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 7.92e-07 | 205 | 52 | 7 | GO:0061008 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 8.18e-07 | 128 | 52 | 6 | GO:0050795 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 8.32e-07 | 69 | 52 | 5 | GO:0030195 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 8.56e-07 | 129 | 52 | 6 | GO:0043406 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 8.94e-07 | 70 | 52 | 5 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 8.94e-07 | 70 | 52 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | cell killing | 9.37e-07 | 307 | 52 | 8 | GO:0001906 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 9.60e-07 | 71 | 52 | 5 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 9.60e-07 | 71 | 52 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 1.03e-06 | 72 | 52 | 5 | GO:0032692 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.03e-06 | 72 | 52 | 5 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 1.07e-06 | 134 | 52 | 6 | GO:0019217 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.08e-06 | 313 | 52 | 8 | GO:0098742 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 1.33e-06 | 139 | 52 | 6 | GO:0007173 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.35e-06 | 76 | 52 | 5 | GO:0042269 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation | 1.52e-06 | 226 | 52 | 7 | GO:0050680 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 1.63e-06 | 449 | 52 | 9 | GO:0002449 | |
| GeneOntologyBiologicalProcess | energy homeostasis | 1.63e-06 | 144 | 52 | 6 | GO:0097009 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 1.74e-06 | 80 | 52 | 5 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.74e-06 | 80 | 52 | 5 | GO:0002715 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 1.79e-06 | 10 | 52 | 3 | GO:0002894 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 1.79e-06 | 10 | 52 | 3 | GO:0001798 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.09e-06 | 83 | 52 | 5 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | ENAM TCF4 CEACAM5 MYO10 PSG6 PSG9 PKHD1 CEACAM6 ROBO1 PSG8 RUNX2 DCC RIMS2 | 2.16e-06 | 1090 | 52 | 13 | GO:0022603 |
| GeneOntologyBiologicalProcess | epithelial cell proliferation | CEACAM5 PSG6 PSG9 CEACAM8 PKHD1 CEACAM6 ROBO1 PSG8 RUNX2 ENPEP | 2.21e-06 | 603 | 52 | 10 | GO:0050673 |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 2.36e-06 | 85 | 52 | 5 | GO:1903670 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.38e-12 | 16 | 52 | 6 | GO:0070021 | |
| GeneOntologyCellularComponent | cell surface | CEACAM5 CD6 FCGR1A FCGR1BP LMO7 PSG6 PSG7 PSG9 IGHG3 FURIN CEACAM8 PKHD1 CEACAM6 ROBO1 PSG8 CUBN DCC ENPEP IGSF3 | 7.49e-12 | 1111 | 52 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | CEACAM5 FCGR1A FCGR1BP PSG6 PSG9 IGHG3 PKHD1 CEACAM6 PSG8 CUBN ENPEP | 4.78e-08 | 519 | 52 | 11 | GO:0009897 |
| GeneOntologyCellularComponent | lateral plasma membrane | 9.34e-08 | 90 | 52 | 6 | GO:0016328 | |
| GeneOntologyCellularComponent | T cell receptor complex | 1.53e-07 | 163 | 52 | 7 | GO:0042101 | |
| GeneOntologyCellularComponent | apical part of cell | CEACAM5 LMO7 PSG6 PSG9 USP9X CEACAM8 PKHD1 CEACAM6 PSG8 CUBN ENPEP | 1.80e-07 | 592 | 52 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | CEACAM5 LMO7 PSG6 PSG9 CEACAM8 PKHD1 CEACAM6 PSG8 CUBN ENPEP | 2.83e-07 | 487 | 52 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | adherens junction | 9.08e-07 | 212 | 52 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.04e-06 | 431 | 52 | 9 | GO:0031253 | |
| GeneOntologyCellularComponent | side of membrane | CEACAM5 FCGR1A FCGR1BP PSG6 PSG9 IGHG3 CEACAM8 PKHD1 CEACAM6 PSG8 CUBN ENPEP | 1.18e-06 | 875 | 52 | 12 | GO:0098552 |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 2.50e-06 | 157 | 52 | 6 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 3.95e-06 | 170 | 52 | 6 | GO:1902911 | |
| GeneOntologyCellularComponent | ciliary membrane | 4.46e-06 | 98 | 52 | 5 | GO:0060170 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 2.43e-05 | 350 | 52 | 7 | GO:0098802 | |
| GeneOntologyCellularComponent | receptor complex | 8.69e-05 | 581 | 52 | 8 | GO:0043235 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.38e-04 | 320 | 52 | 6 | GO:0016323 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.77e-04 | 335 | 52 | 6 | GO:0061695 | |
| GeneOntologyCellularComponent | basal plasma membrane | 2.39e-04 | 354 | 52 | 6 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 3.39e-04 | 378 | 52 | 6 | GO:0045178 | |
| GeneOntologyCellularComponent | cell-cell junction | 6.18e-04 | 591 | 52 | 7 | GO:0005911 | |
| GeneOntologyCellularComponent | cilium | 1.58e-03 | 898 | 52 | 8 | GO:0005929 | |
| GeneOntologyCellularComponent | coated vesicle | 1.97e-03 | 360 | 52 | 5 | GO:0030135 | |
| GeneOntologyCellularComponent | anchoring junction | 2.66e-03 | 976 | 52 | 8 | GO:0070161 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 2.85e-03 | 237 | 52 | 4 | GO:0030136 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 3.15e-03 | 785 | 52 | 7 | GO:0098797 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 5.85e-03 | 147 | 52 | 3 | GO:0030665 | |
| MousePheno | increased skeletal muscle triglyceride level | 5.42e-11 | 21 | 47 | 6 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 1.33e-10 | 24 | 47 | 6 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 2.91e-10 | 27 | 47 | 6 | MP:0009286 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 7.17e-10 | 31 | 47 | 6 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 7.17e-10 | 31 | 47 | 6 | MP:0008964 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.56e-09 | 35 | 47 | 6 | MP:0031618 | |
| MousePheno | increased insulin secretion | 1.64e-09 | 64 | 47 | 7 | MP:0003058 | |
| MousePheno | abnormal muscle triglyceride level | 1.87e-09 | 36 | 47 | 6 | MP:0031412 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 2.07e-09 | 17 | 47 | 5 | MP:0031047 | |
| MousePheno | decreased muscle cell glucose uptake | 3.11e-09 | 39 | 47 | 6 | MP:0030022 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.00e-08 | 47 | 47 | 6 | MP:0031617 | |
| MousePheno | decreased cellular glucose uptake | 2.12e-08 | 53 | 47 | 6 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 2.37e-08 | 54 | 47 | 6 | MP:0010953 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 3.20e-08 | 28 | 47 | 5 | MP:0020950 | |
| MousePheno | abnormal lipid oxidation | 5.01e-08 | 61 | 47 | 6 | MP:0010951 | |
| MousePheno | abnormal muscle cell glucose uptake | 8.88e-08 | 67 | 47 | 6 | MP:0004130 | |
| MousePheno | abnormal carbon dioxide production | 8.88e-08 | 67 | 47 | 6 | MP:0008962 | |
| MousePheno | abnormal insulin secretion | 8.91e-08 | 171 | 47 | 8 | MP:0003564 | |
| MousePheno | abnormal endocrine pancreas secretion | 1.11e-07 | 176 | 47 | 8 | MP:0014195 | |
| MousePheno | abnormal pancreas secretion | 1.50e-07 | 183 | 47 | 8 | MP:0002694 | |
| MousePheno | decreased oxygen consumption | 2.40e-07 | 79 | 47 | 6 | MP:0005290 | |
| MousePheno | abnormal pancreatic beta cell physiology | 2.55e-07 | 196 | 47 | 8 | MP:0003562 | |
| MousePheno | polyphagia | 2.59e-07 | 80 | 47 | 6 | MP:0001433 | |
| MousePheno | abnormal endocrine pancreas physiology | 3.21e-07 | 202 | 47 | 8 | MP:0010147 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 3.40e-07 | 44 | 47 | 5 | MP:0031023 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 5.89e-07 | 49 | 47 | 5 | MP:0020948 | |
| MousePheno | abnormal cellular glucose uptake | 1.10e-06 | 102 | 47 | 6 | MP:0003925 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 1.64e-06 | 60 | 47 | 5 | MP:0009790 | |
| MousePheno | decreased respiratory quotient | 1.71e-06 | 110 | 47 | 6 | MP:0010379 | |
| MousePheno | obese | 2.00e-06 | 113 | 47 | 6 | MP:0001261 | |
| MousePheno | increased lean body mass | 2.25e-06 | 354 | 47 | 9 | MP:0003960 | |
| MousePheno | decreased energy expenditure | 2.71e-06 | 119 | 47 | 6 | MP:0004890 | |
| MousePheno | abnormal endocrine gland physiology | 2.77e-06 | 363 | 47 | 9 | MP:0013561 | |
| MousePheno | decreased circulating triglyceride level | 3.28e-06 | 275 | 47 | 8 | MP:0002644 | |
| MousePheno | increased circulating leptin level | 3.60e-06 | 125 | 47 | 6 | MP:0005669 | |
| MousePheno | abnormal vascular wound healing | 4.37e-06 | 73 | 47 | 5 | MP:0004883 | |
| MousePheno | abnormal pancreas physiology | 5.10e-06 | 292 | 47 | 8 | MP:0002693 | |
| MousePheno | increased incidence of tumors by chemical induction | 7.23e-06 | 141 | 47 | 6 | MP:0004499 | |
| MousePheno | decreased susceptibility to Riboviria infection | 7.76e-06 | 82 | 47 | 5 | MP:0020914 | |
| MousePheno | abnormal glycogen homeostasis | 8.16e-06 | 144 | 47 | 6 | MP:0005438 | |
| MousePheno | increased tumor incidence | 8.24e-06 | 530 | 47 | 10 | MP:0002020 | |
| MousePheno | decreased triglyceride level | 1.83e-05 | 348 | 47 | 8 | MP:0005318 | |
| MousePheno | decreased lipid level | ENAM TMPRSS15 CEACAM5 MALRD1 PSG6 PSG9 AAK1 CEACAM8 KIAA1549 CEACAM6 PSG8 | 2.18e-05 | 727 | 47 | 11 | MP:0014461 |
| MousePheno | increased incidence of induced tumors | 2.32e-05 | 173 | 47 | 6 | MP:0002021 | |
| MousePheno | abnormal respiratory quotient | 2.73e-05 | 178 | 47 | 6 | MP:0004129 | |
| MousePheno | increased food intake | 3.82e-05 | 189 | 47 | 6 | MP:0011939 | |
| MousePheno | abnormal tumor incidence | 3.93e-05 | 635 | 47 | 10 | MP:0002019 | |
| MousePheno | abnormal oxygen consumption | 4.55e-05 | 195 | 47 | 6 | MP:0005288 | |
| MousePheno | abnormal tumor susceptibility | 4.79e-05 | 650 | 47 | 10 | MP:0002166 | |
| MousePheno | insulin resistance | 4.82e-05 | 197 | 47 | 6 | MP:0005331 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 4.93e-05 | 120 | 47 | 5 | MP:0009786 | |
| MousePheno | decreased susceptibility to viral infection | 5.99e-05 | 125 | 47 | 5 | MP:0002410 | |
| MousePheno | abnormal intrahepatic bile duct morphology | 6.61e-05 | 4 | 47 | 2 | MP:0009497 | |
| MousePheno | abnormal gland physiology | CEACAM5 PSG6 PSG9 CEACAM8 CEACAM6 ROBO1 KCNK16 PSG8 RUNX2 RIMS2 | 8.01e-05 | 691 | 47 | 10 | MP:0002164 |
| MousePheno | decreased susceptibility to autoimmune hemolytic anemia | 1.10e-04 | 5 | 47 | 2 | MP:0004828 | |
| MousePheno | abnormal circulating leptin level | 1.31e-04 | 236 | 47 | 6 | MP:0005667 | |
| MousePheno | abnormal colon morphology | 1.51e-04 | 152 | 47 | 5 | MP:0000495 | |
| MousePheno | neoplasm | 1.53e-04 | 747 | 47 | 10 | MP:0002006 | |
| MousePheno | abnormal eating behavior | 1.55e-04 | 604 | 47 | 9 | MP:0001431 | |
| MousePheno | abnormal lean body mass | ENAM CEACAM5 PSG6 PSG9 CEACAM8 CEACAM6 TMEM108 PSG8 SSBP2 RUNX2 | 1.56e-04 | 749 | 47 | 10 | MP:0003959 |
| MousePheno | impaired glucose tolerance | 1.76e-04 | 480 | 47 | 8 | MP:0005293 | |
| MousePheno | abnormal abdominal fat pad morphology | 2.31e-04 | 262 | 47 | 6 | MP:0000010 | |
| MousePheno | abnormal incidence of induced tumors | 2.66e-04 | 269 | 47 | 6 | MP:0013151 | |
| MousePheno | abnormal circulating triglyceride level | 2.88e-04 | 516 | 47 | 8 | MP:0011969 | |
| MousePheno | abnormal blood vessel physiology | 3.18e-04 | 394 | 47 | 7 | MP:0000249 | |
| MousePheno | increased circulating insulin level | 3.49e-04 | 283 | 47 | 6 | MP:0002079 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 3.69e-04 | 286 | 47 | 6 | MP:0008873 | |
| MousePheno | abnormal vasculature physiology | 3.70e-04 | 404 | 47 | 7 | MP:0031170 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 3.85e-04 | 186 | 47 | 5 | MP:0020912 | |
| MousePheno | increased adenocarcinoma incidence | 3.89e-04 | 103 | 47 | 4 | MP:0009308 | |
| MousePheno | abnormal intestine morphology | 4.21e-04 | 546 | 47 | 8 | MP:0000477 | |
| MousePheno | abnormal consumption behavior | 4.38e-04 | 695 | 47 | 9 | MP:0002069 | |
| MousePheno | abnormal wound healing | 4.56e-04 | 193 | 47 | 5 | MP:0005023 | |
| MousePheno | delayed tooth eruption | 4.89e-04 | 10 | 47 | 2 | MP:0003053 | |
| MousePheno | abnormal macrophage antigen presentation | 4.89e-04 | 10 | 47 | 2 | MP:0002454 | |
| MousePheno | increased total body fat amount | 4.95e-04 | 424 | 47 | 7 | MP:0010024 | |
| MousePheno | increased carcinoma incidence | 5.01e-04 | 197 | 47 | 5 | MP:0002038 | |
| MousePheno | abnormal energy expenditure | 5.95e-04 | 313 | 47 | 6 | MP:0005450 | |
| MousePheno | abnormal digestive system morphology | CEACAM5 PSG6 PSG9 FURIN PKHD1 CEACAM6 ROBO1 PSG8 SSBP2 RUNX2 DCC IGSF3 | 5.97e-04 | 1233 | 47 | 12 | MP:0000462 |
| MousePheno | abnormal fat pad morphology | 6.05e-04 | 314 | 47 | 6 | MP:0005334 | |
| MousePheno | abnormal energy homeostasis | 6.91e-04 | 322 | 47 | 6 | MP:0005448 | |
| MousePheno | abnormal adipose tissue amount | ENAM TMPRSS15 CEACAM5 PSG6 PSG9 CEACAM8 KIAA1549 CEACAM6 TMEM108 PSG8 SSBP2 | 7.10e-04 | 1077 | 47 | 11 | MP:0005452 |
| MousePheno | abnormal enamel organ morphology | 7.15e-04 | 12 | 47 | 2 | MP:0010747 | |
| MousePheno | failure of initiation of embryo turning | 8.71e-04 | 56 | 47 | 3 | MP:0004180 | |
| MousePheno | abnormal muscle morphology | FOXM1 CEACAM5 ERG LMO7 PSG6 PSG9 CEACAM8 CEACAM6 ROBO1 PSG8 IGSF3 | 8.87e-04 | 1106 | 47 | 11 | MP:0002108 |
| MousePheno | digestive/alimentary phenotype | ENAM CEACAM5 PSG6 PSG9 FURIN PKHD1 CEACAM6 ROBO1 PSG8 SSBP2 RUNX2 DCC IGSF3 | 1.01e-03 | 1500 | 47 | 13 | MP:0005381 |
| MousePheno | abnormal food intake | 1.04e-03 | 481 | 47 | 7 | MP:0005449 | |
| MousePheno | abnormal glucose tolerance | 1.07e-03 | 787 | 47 | 9 | MP:0005291 | |
| MousePheno | increased triglyceride level | 1.13e-03 | 354 | 47 | 6 | MP:0005317 | |
| MousePheno | increased malignant tumor incidence | 1.15e-03 | 237 | 47 | 5 | MP:0002018 | |
| MousePheno | abnormal triglyceride level | 1.18e-03 | 639 | 47 | 8 | MP:0000187 | |
| MousePheno | increased hormone level | 1.21e-03 | 641 | 47 | 8 | MP:0014454 | |
| MousePheno | increased total tissue mass | 1.30e-03 | 364 | 47 | 6 | MP:0012323 | |
| MousePheno | increased body weight | 1.30e-03 | 364 | 47 | 6 | MP:0001260 | |
| MousePheno | abnormal blood cell morphology/development | 1.37e-03 | 986 | 47 | 10 | MP:0002429 | |
| MousePheno | abnormal circulating insulin level | 1.38e-03 | 505 | 47 | 7 | MP:0001560 | |
| MousePheno | abnormal skeletal muscle morphology | 1.43e-03 | 508 | 47 | 7 | MP:0000759 | |
| MousePheno | decreased susceptibility to infection | 1.59e-03 | 255 | 47 | 5 | MP:0002409 | |
| MousePheno | abnormal dendritic cell differentiation | 2.02e-03 | 20 | 47 | 2 | MP:0008115 | |
| MousePheno | respiratory failure | 2.25e-03 | 165 | 47 | 4 | MP:0001953 | |
| Domain | Ig_2 | 4.11e-13 | 73 | 52 | 9 | PF13895 | |
| Domain | IGc2 | CEACAM5 FCGR1A FCGR1BP PSG6 PSG7 PSG9 CEACAM8 CEACAM6 ROBO1 PSG8 DCC IGSF3 | 1.57e-12 | 235 | 52 | 12 | SM00408 |
| Domain | Ig_sub2 | CEACAM5 FCGR1A FCGR1BP PSG6 PSG7 PSG9 CEACAM8 CEACAM6 ROBO1 PSG8 DCC IGSF3 | 1.57e-12 | 235 | 52 | 12 | IPR003598 |
| Domain | IG_LIKE | CEACAM5 FCGR1A FCGR1BP PSG6 PSG7 PSG9 IGHG3 CEACAM8 CEACAM6 ROBO1 PSG8 DCC IGSF3 | 6.10e-10 | 491 | 52 | 13 | PS50835 |
| Domain | Ig-like_dom | CEACAM5 FCGR1A FCGR1BP PSG6 PSG7 PSG9 IGHG3 CEACAM8 CEACAM6 ROBO1 PSG8 DCC IGSF3 | 8.18e-10 | 503 | 52 | 13 | IPR007110 |
| Domain | IG | CEACAM5 FCGR1A FCGR1BP PSG6 PSG7 PSG9 CEACAM8 CEACAM6 ROBO1 PSG8 DCC IGSF3 | 1.35e-09 | 421 | 52 | 12 | SM00409 |
| Domain | Ig_sub | CEACAM5 FCGR1A FCGR1BP PSG6 PSG7 PSG9 CEACAM8 CEACAM6 ROBO1 PSG8 DCC IGSF3 | 1.35e-09 | 421 | 52 | 12 | IPR003599 |
| Domain | ig | 2.44e-09 | 190 | 52 | 9 | PF00047 | |
| Domain | Immunoglobulin | 2.44e-09 | 190 | 52 | 9 | IPR013151 | |
| Domain | Ig_V-set | 3.66e-09 | 199 | 52 | 9 | IPR013106 | |
| Domain | Ig-like_fold | CEACAM5 FCGR1A FCGR1BP PSG6 PSG7 PSG9 IGHG3 CEACAM8 PKHD1 CEACAM6 ROBO1 PSG8 DCC IGSF3 | 4.99e-09 | 706 | 52 | 14 | IPR013783 |
| Domain | - | CEACAM5 FCGR1A FCGR1BP PSG6 PSG7 PSG9 CEACAM8 PKHD1 CEACAM6 ROBO1 PSG8 DCC IGSF3 | 2.24e-08 | 663 | 52 | 13 | 2.60.40.10 |
| Domain | V-set | 3.96e-08 | 184 | 52 | 8 | PF07686 | |
| Domain | Ago_hook | 2.28e-05 | 3 | 52 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 2.28e-05 | 3 | 52 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 2.28e-05 | 3 | 52 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 2.28e-05 | 3 | 52 | 2 | PF16608 | |
| Domain | Ig_I-set | 1.82e-04 | 190 | 52 | 5 | IPR013098 | |
| Domain | I-set | 1.82e-04 | 190 | 52 | 5 | PF07679 | |
| Domain | Chromo_dom_subgr | 3.37e-04 | 10 | 52 | 2 | IPR017984 | |
| Domain | Crotonase_core_superfam | 1.01e-03 | 17 | 52 | 2 | IPR001753 | |
| Domain | ECH_1 | 1.01e-03 | 17 | 52 | 2 | PF00378 | |
| Domain | MAM | 1.01e-03 | 17 | 52 | 2 | SM00137 | |
| Domain | MAM | 1.13e-03 | 18 | 52 | 2 | PF00629 | |
| Domain | MAM_dom | 1.13e-03 | 18 | 52 | 2 | IPR000998 | |
| Domain | MAM_2 | 1.13e-03 | 18 | 52 | 2 | PS50060 | |
| Domain | SRCR | 1.54e-03 | 21 | 52 | 2 | PF00530 | |
| Domain | SR | 2.19e-03 | 25 | 52 | 2 | SM00202 | |
| Domain | - | 2.19e-03 | 25 | 52 | 2 | 3.10.250.10 | |
| Domain | SRCR_1 | 2.37e-03 | 26 | 52 | 2 | PS00420 | |
| Domain | SRCR_2 | 2.37e-03 | 26 | 52 | 2 | PS50287 | |
| Domain | SRCR-like_dom | 2.37e-03 | 26 | 52 | 2 | IPR017448 | |
| Domain | Chromo | 2.37e-03 | 26 | 52 | 2 | PF00385 | |
| Domain | SRCR | 2.55e-03 | 27 | 52 | 2 | IPR001190 | |
| Domain | CHROMO_1 | 2.74e-03 | 28 | 52 | 2 | PS00598 | |
| Domain | CHROMO_2 | 2.74e-03 | 28 | 52 | 2 | PS50013 | |
| Domain | Chromodomain-like | 3.57e-03 | 32 | 52 | 2 | IPR016197 | |
| Domain | Chromo/shadow_dom | 3.80e-03 | 33 | 52 | 2 | IPR000953 | |
| Domain | CHROMO | 3.80e-03 | 33 | 52 | 2 | SM00298 | |
| Domain | LDLR_class-A_CS | 5.54e-03 | 40 | 52 | 2 | IPR023415 | |
| Domain | Ldl_recept_a | 6.97e-03 | 45 | 52 | 2 | PF00057 | |
| Domain | PDZ | 7.11e-03 | 141 | 52 | 3 | PF00595 | |
| Domain | - | 7.28e-03 | 46 | 52 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 7.90e-03 | 48 | 52 | 2 | PS01209 | |
| Domain | PDZ | 8.11e-03 | 148 | 52 | 3 | SM00228 | |
| Domain | CUB | 8.22e-03 | 49 | 52 | 2 | PF00431 | |
| Domain | LDLRA_2 | 8.22e-03 | 49 | 52 | 2 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 8.22e-03 | 49 | 52 | 2 | IPR002172 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 2.37e-07 | 99 | 38 | 6 | MM14624 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 7.38e-07 | 194 | 38 | 7 | M16312 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 3.70e-06 | 158 | 38 | 6 | MM14812 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | CEACAM5 GLB1 FCGR1A FCGR1BP MYO10 PSG6 PSG9 IGHG3 CEACAM8 CEACAM6 PSG8 | 4.19e-05 | 995 | 38 | 11 | MM14661 |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 5.65e-05 | 28 | 38 | 3 | M48253 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.99e-05 | 258 | 38 | 6 | MM14572 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 6.76e-05 | 161 | 38 | 5 | M27871 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.05e-04 | 6 | 38 | 2 | MM15083 | |
| Pathway | REACTOME_FIBRONECTIN_MATRIX_FORMATION | 1.05e-04 | 6 | 38 | 2 | M26970 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.40e-04 | 188 | 38 | 5 | MM15828 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.47e-04 | 7 | 38 | 2 | M46421 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 2.22e-04 | 44 | 38 | 3 | M875 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 2.42e-04 | 114 | 38 | 4 | MM14814 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 2.52e-04 | 9 | 38 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 2.52e-04 | 9 | 38 | 2 | M46436 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 2.87e-04 | 48 | 38 | 3 | MM17214 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 3.06e-04 | 49 | 38 | 3 | M48250 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 3.14e-04 | 10 | 38 | 2 | M48013 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 3.14e-04 | 10 | 38 | 2 | M27348 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 3.75e-04 | 511 | 38 | 7 | MM15330 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 4.54e-04 | 56 | 38 | 3 | MM14815 | |
| Pathway | WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS | 5.42e-04 | 13 | 38 | 2 | M39527 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 5.42e-04 | 13 | 38 | 2 | M46434 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ENAM CEACAM5 GLB1 LMO7 PSG6 PSG9 USP9X FURIN CEACAM8 CEACAM6 PSG8 | 8.00e-04 | 1389 | 38 | 11 | MM15307 |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 9.38e-04 | 17 | 38 | 2 | M27788 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 1.18e-03 | 19 | 38 | 2 | M48238 | |
| Pathway | REACTOME_HEMOSTASIS | 1.99e-03 | 679 | 38 | 7 | M8395 | |
| Pathway | PID_NETRIN_PATHWAY | 3.33e-03 | 32 | 38 | 2 | M108 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 3.33e-03 | 32 | 38 | 2 | M48012 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 3.33e-03 | 32 | 38 | 2 | M27900 | |
| Pubmed | 2.78e-14 | 14 | 53 | 6 | 28567513 | ||
| Pubmed | 2.78e-14 | 14 | 53 | 6 | 8207827 | ||
| Pubmed | 2.78e-14 | 14 | 53 | 6 | 11994468 | ||
| Pubmed | CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. | 2.78e-14 | 14 | 53 | 6 | 27161904 | |
| Pubmed | 2.78e-14 | 14 | 53 | 6 | 20381490 | ||
| Pubmed | 2.78e-14 | 14 | 53 | 6 | 23070997 | ||
| Pubmed | 2.78e-14 | 14 | 53 | 6 | 10491101 | ||
| Pubmed | 2.78e-14 | 14 | 53 | 6 | 22159884 | ||
| Pubmed | 4.63e-14 | 15 | 53 | 6 | 24948196 | ||
| Pubmed | 4.63e-14 | 15 | 53 | 6 | 20410265 | ||
| Pubmed | 4.63e-14 | 15 | 53 | 6 | 26586918 | ||
| Pubmed | 7.40e-14 | 16 | 53 | 6 | 25085348 | ||
| Pubmed | Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. | 7.40e-14 | 16 | 53 | 6 | 11284729 | |
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 8.63e-12 | 13 | 53 | 5 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 8.63e-12 | 13 | 53 | 5 | 1985902 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 10964771 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 8.63e-12 | 13 | 53 | 5 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 8.63e-12 | 13 | 53 | 5 | 16638824 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 20044046 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 32150576 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 22469976 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 8.63e-12 | 13 | 53 | 5 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 8.63e-12 | 13 | 53 | 5 | 28035001 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 8.63e-12 | 13 | 53 | 5 | 12832451 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 8.63e-12 | 13 | 53 | 5 | 15316023 | |
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 8.63e-12 | 13 | 53 | 5 | 21670291 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 22162753 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 8.63e-12 | 13 | 53 | 5 | 23935487 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 2702644 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 8380065 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 1279194 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 15331748 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 8.63e-12 | 13 | 53 | 5 | 22406619 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 7628460 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 25724769 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 26374765 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 8.63e-12 | 13 | 53 | 5 | 25972571 | |
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 8.63e-12 | 13 | 53 | 5 | 22092845 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 11801635 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 28913658 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 19008452 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 8.63e-12 | 13 | 53 | 5 | 15220458 | |
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 8.63e-12 | 13 | 53 | 5 | 8500759 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 8.63e-12 | 13 | 53 | 5 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 8.63e-12 | 13 | 53 | 5 | 23800882 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 15207636 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 19285068 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 21760897 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 8.63e-12 | 13 | 53 | 5 | 1326665 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 21081647 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 8.63e-12 | 13 | 53 | 5 | 39168268 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 11483763 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 8402684 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 2164599 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 16619040 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 8.63e-12 | 13 | 53 | 5 | 8209741 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 8.63e-12 | 13 | 53 | 5 | 21949477 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 29396368 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 26219866 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 18003729 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 26284027 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 2133556 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 32521208 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 8.63e-12 | 13 | 53 | 5 | 33352461 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 19406938 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 38381498 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 20739537 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 8.63e-12 | 13 | 53 | 5 | 29967450 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 1633107 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 8.63e-12 | 13 | 53 | 5 | 19358828 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 8.63e-12 | 13 | 53 | 5 | 27695943 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 20404914 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 16680193 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 26911181 | ||
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 1653760 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 8.63e-12 | 13 | 53 | 5 | 32027621 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 8.63e-12 | 13 | 53 | 5 | 27777319 | |
| Pubmed | 8.63e-12 | 13 | 53 | 5 | 18848945 | ||
| Pubmed | 1.34e-11 | 14 | 53 | 5 | 37531413 | ||
| Pubmed | 1.34e-11 | 14 | 53 | 5 | 23780386 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.34e-11 | 14 | 53 | 5 | 34666041 | |
| Pubmed | 1.34e-11 | 14 | 53 | 5 | 19700760 | ||
| Pubmed | 1.34e-11 | 14 | 53 | 5 | 34619794 | ||
| Pubmed | Expression patterns of CD66a and CD117 in the mouse submandibular gland. | 1.34e-11 | 14 | 53 | 5 | 25498293 | |
| Pubmed | Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling. | 1.34e-11 | 14 | 53 | 5 | 29746166 | |
| Pubmed | 1.34e-11 | 14 | 53 | 5 | 9212243 | ||
| Pubmed | CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo. | 1.34e-11 | 14 | 53 | 5 | 27572314 | |
| Cytoband | 19q13.2 | 4.25e-08 | 164 | 54 | 6 | 19q13.2 | |
| Cytoband | 10p12.31 | 3.09e-04 | 22 | 54 | 2 | 10p12.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 4.78e-04 | 1192 | 54 | 7 | chr19q13 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 3.41e-09 | 11 | 34 | 4 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.86e-08 | 163 | 34 | 7 | 590 | |
| GeneFamily | Immunoglobulin like domain containing | 5.97e-08 | 193 | 34 | 7 | 594 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 1.20e-05 | 24 | 34 | 3 | 906 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.27e-05 | 394 | 34 | 6 | 471 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.00e-03 | 25 | 34 | 2 | 775 | |
| GeneFamily | PDZ domain containing | 2.88e-03 | 152 | 34 | 3 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.39e-03 | 161 | 34 | 3 | 593 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 1.42e-10 | 75 | 52 | 7 | MM605 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 4.88e-09 | 32 | 52 | 5 | MM2 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 5.86e-09 | 201 | 52 | 8 | MM1006 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 7.83e-09 | 35 | 52 | 5 | MM757 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | TCF4 CEACAM5 GLB1 FCGR1A FCGR1BP PSG6 PSG9 USP9X CEACAM8 CEACAM6 TRIM77 PSG8 ENPEP | 1.05e-08 | 871 | 52 | 13 | MM1005 |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 4.05e-08 | 48 | 52 | 5 | MM531 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 2.80e-07 | 135 | 52 | 6 | MM965 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | 2.91e-07 | 463 | 52 | 9 | MM1011 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 8.24e-07 | 87 | 52 | 5 | MM851 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 1.59e-06 | 568 | 52 | 9 | MM3824 | |
| Coexpression | QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_35DY_UP | 3.29e-06 | 15 | 52 | 3 | M40982 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 4.69e-06 | 219 | 52 | 6 | MM3826 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 5.55e-06 | 128 | 52 | 5 | MM1000 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 9.53e-06 | 143 | 52 | 5 | MM989 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 1.59e-05 | 159 | 52 | 5 | MM760 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 3.05e-05 | 182 | 52 | 5 | MM993 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 3.53e-05 | 93 | 52 | 4 | M40279 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | 4.78e-05 | 200 | 52 | 5 | M8618 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 4.89e-05 | 201 | 52 | 5 | MM1294 | |
| Coexpression | CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_UP | 5.76e-05 | 6 | 52 | 2 | M41151 | |
| Coexpression | NEWMAN_ERCC6_TARGETS_DN | 6.40e-05 | 39 | 52 | 3 | M6239 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 7.67e-05 | 221 | 52 | 5 | M39222 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | 8.47e-05 | 534 | 52 | 7 | MM1050 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 9.25e-05 | 230 | 52 | 5 | MM986 | |
| Coexpression | BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES | 1.61e-04 | 259 | 52 | 5 | M40029 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP | 1.68e-04 | 139 | 52 | 4 | M6754 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 1.72e-04 | 417 | 52 | 6 | M39224 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 2.47e-04 | 284 | 52 | 5 | MM987 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 3.28e-04 | 302 | 52 | 5 | MM16604 | |
| Coexpression | BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE | 3.52e-04 | 69 | 52 | 3 | M2533 | |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN | 3.63e-04 | 170 | 52 | 4 | M5649 | |
| Coexpression | DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS | 3.71e-04 | 171 | 52 | 4 | M40134 | |
| Coexpression | SU_KIDNEY | 3.99e-04 | 15 | 52 | 2 | M5672 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 4.07e-04 | 490 | 52 | 6 | MM1001 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 4.23e-04 | 177 | 52 | 4 | M39245 | |
| Coexpression | SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B | 4.55e-04 | 16 | 52 | 2 | M1530 | |
| Coexpression | GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP | 4.89e-04 | 184 | 52 | 4 | M6141 | |
| Coexpression | GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN | 5.74e-04 | 192 | 52 | 4 | M7571 | |
| Coexpression | GSE15659_TREG_VS_TCONV_UP | 5.85e-04 | 193 | 52 | 4 | M3534 | |
| Coexpression | GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN | 5.97e-04 | 194 | 52 | 4 | M6492 | |
| Coexpression | GSE28130_ACTIVATED_VS_INDUCEED_TREG_DN | 6.20e-04 | 196 | 52 | 4 | M8345 | |
| Coexpression | GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP | 6.32e-04 | 197 | 52 | 4 | M7264 | |
| Coexpression | GSE22886_NEUTROPHIL_VS_MONOCYTE_UP | 6.32e-04 | 197 | 52 | 4 | M4466 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 6.58e-04 | 352 | 52 | 5 | M17471 | |
| Coexpression | GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN | 6.69e-04 | 200 | 52 | 4 | M5137 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN | 6.69e-04 | 200 | 52 | 4 | M8208 | |
| Coexpression | GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN | 6.69e-04 | 200 | 52 | 4 | M7850 | |
| Coexpression | GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN | 6.69e-04 | 200 | 52 | 4 | M3435 | |
| Coexpression | KAYO_CALORIE_RESTRICTION_MUSCLE_DN | 6.94e-04 | 87 | 52 | 3 | M4270 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_AEROCYTE | 6.94e-04 | 87 | 52 | 3 | M45745 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | TCF4 SYNPO2 FAM193A ERG LMO7 USP9X KIAA1549 ROBO1 RUNX2 RIMS2 IGSF3 | 1.66e-06 | 769 | 51 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 7.74e-06 | 429 | 51 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.11e-05 | 377 | 51 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_200 | 5.26e-05 | 169 | 51 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | 6.93e-05 | 428 | 51 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.26e-07 | 130 | 54 | 5 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.84e-06 | 183 | 54 | 5 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-06 | 184 | 54 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-06 | 184 | 54 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-06 | 184 | 54 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 190 | 54 | 5 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.49e-06 | 191 | 54 | 5 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.96e-06 | 196 | 54 | 5 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.96e-06 | 196 | 54 | 5 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | control-CD8+_T_naive|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.27e-06 | 199 | 54 | 5 | 6a61ce7404c65e506091fee99a2001f5a9b39f31 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_T_naive|Control / Disease, condition lineage and cell class | 4.37e-06 | 200 | 54 | 5 | 906de95adc9716982ab32f216dddeb52639bad06 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.25e-05 | 136 | 54 | 4 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.52e-05 | 140 | 54 | 4 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | TCGA-Kidney|World / Sample_Type by Project: Shred V9 | 3.38e-05 | 151 | 54 | 4 | e31974c0d0a0c644205a0ee6013ab74a09d8a306 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 3.65e-05 | 154 | 54 | 4 | 8a8c3851888ab86ca2b13ccc042cde1fef8d88f8 | |
| ToppCell | lymphoid-B_cell-pro-B|World / Lineage, cell class and subclass | 4.35e-05 | 161 | 54 | 4 | 23138e579f07d5a6f20d41457cb573b4ac95a4ef | |
| ToppCell | C_02|World / shred on cell type and cluster | 4.78e-05 | 165 | 54 | 4 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.78e-05 | 165 | 54 | 4 | 79c6ad394266ff092029375883660028e944a3c8 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Plasmablast|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.89e-05 | 166 | 54 | 4 | 0cc3b9681bc000a1b00d3b60f79f16eea1c2e2e1 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 5.25e-05 | 169 | 54 | 4 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 169 | 54 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-05 | 170 | 54 | 4 | 985c2d5962100fab0d95bee39f382ccbe799331e | |
| ToppCell | Immune_cells-pro-B|Immune_cells / Lineage and Cell class | 5.62e-05 | 172 | 54 | 4 | 096636f2589fa56d15942aac96641c16fd5fa78d | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 5.88e-05 | 174 | 54 | 4 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 176 | 54 | 4 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 176 | 54 | 4 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | B_cell_maturation-CD34+_pre-plamsa|World / Lineage and Cell class | 6.28e-05 | 177 | 54 | 4 | 3ff06100deee9bee852a52078666999a9f7beaf1 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.42e-05 | 178 | 54 | 4 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Late_pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.42e-05 | 178 | 54 | 4 | 4e28a8bd5a603518bfe993712ab785308691b5ff | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.85e-05 | 181 | 54 | 4 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.85e-05 | 181 | 54 | 4 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.85e-05 | 181 | 54 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.00e-05 | 182 | 54 | 4 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.00e-05 | 182 | 54 | 4 | 3a3ed195c15d33d46a2f395cb93018e4bba28353 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 7.30e-05 | 184 | 54 | 4 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | Leuk-UTI-Other-RBC|Leuk-UTI / Disease, Lineage and Cell Type | 7.45e-05 | 185 | 54 | 4 | 5b5dd856d6efc0539d92533cff134bbc3f98be45 | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 7.45e-05 | 185 | 54 | 4 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | Leuk-UTI-Other|Leuk-UTI / Disease, Lineage and Cell Type | 7.45e-05 | 185 | 54 | 4 | 895e8087e97ac0eab3446385e6e0dd24bea7f42c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-05 | 186 | 54 | 4 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 54 | 4 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | control-Lymphocytic-Plasmablast|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.77e-05 | 187 | 54 | 4 | 94a44b31ce9fe6fb4758769018fb746e93c8f043 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 54 | 4 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 54 | 4 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 54 | 4 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.77e-05 | 187 | 54 | 4 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 54 | 4 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 54 | 4 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 7.77e-05 | 187 | 54 | 4 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.93e-05 | 188 | 54 | 4 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | severe_COVID-19-Plasmablast|World / disease group, cell group and cell class (v2) | 7.93e-05 | 188 | 54 | 4 | 25ca19af4ac419a0f5026a6ccbd8b554b268a6f3 | |
| ToppCell | ASK454-Epithelial-Type_1|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.93e-05 | 188 | 54 | 4 | 13f8ce8f24ac7d7ed87f4ae3b8f4096de29383c2 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.10e-05 | 189 | 54 | 4 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 8.10e-05 | 189 | 54 | 4 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 189 | 54 | 4 | e60a3d6aa84788c29f23439f1c747431ea581bc3 | |
| ToppCell | severe_COVID-19-Plasmablast|severe_COVID-19 / disease group, cell group and cell class (v2) | 8.10e-05 | 189 | 54 | 4 | 953143b2c2e87a4d8ef033a5fbb155fe62e9c78e | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 189 | 54 | 4 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | control-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.10e-05 | 189 | 54 | 4 | 2e4c2618d06120f83cb4887dd3497b81984a8607 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 189 | 54 | 4 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 8.26e-05 | 190 | 54 | 4 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.26e-05 | 190 | 54 | 4 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | T_cells-Effector_memory_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.26e-05 | 190 | 54 | 4 | 13dc3a0aaa554f63eabac37726bd1f11b66fb3dd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-05 | 190 | 54 | 4 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-05 | 191 | 54 | 4 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | B_cell_maturation-CD34+_pre-plamsa|B_cell_maturation / Lineage and Cell class | 8.43e-05 | 191 | 54 | 4 | 4ee160a863d4fb9c4c9449633b9f337db8871992 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-05 | 191 | 54 | 4 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | hematopoetic_progenitors-CD34+_CLP|World / Lineage and Cell class | 8.43e-05 | 191 | 54 | 4 | 32f2537c97c9984629d61c6f34a337f555146ad4 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 192 | 54 | 4 | 03dcd9405d3d76fc7455066ba5d83c09cd17072d | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.60e-05 | 192 | 54 | 4 | 0445fdc670fa7b847dcd0a061d7736ddcf3519ba | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.60e-05 | 192 | 54 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | ILEUM-inflamed-(1)_Th17_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.78e-05 | 193 | 54 | 4 | 0663c57e1b8b8dd70d617d029fc7bdbbda8c1208 | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 8.78e-05 | 193 | 54 | 4 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.78e-05 | 193 | 54 | 4 | d371403b51281a6e37652fa8dc1b2dd81d2ab371 | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.78e-05 | 193 | 54 | 4 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.78e-05 | 193 | 54 | 4 | 6436d3bfce02d137b76e5c4c8b2fe27974c57c99 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.78e-05 | 193 | 54 | 4 | ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.78e-05 | 193 | 54 | 4 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.78e-05 | 193 | 54 | 4 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.78e-05 | 193 | 54 | 4 | 3cde93bbfc1ae6fb586ae6b7aaa6ed8b5eee28a4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.78e-05 | 193 | 54 | 4 | d755dc6de4fbd4d8f5d8a88aac497e7b9e8b89de | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 8.78e-05 | 193 | 54 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.95e-05 | 194 | 54 | 4 | 2e2019a7bf57f257f0ff9b24eacff59dbb952ebb | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.95e-05 | 194 | 54 | 4 | d788d5bd1e651706e7e2d54ada546a5e84f86ff0 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-05 | 194 | 54 | 4 | 52ecec2618c3bb5fdd7fb06b5a40bd6f0aedfe1d | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.95e-05 | 194 | 54 | 4 | 23318a1b55895b5166c6151f488a94a09b4627ff | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.95e-05 | 194 | 54 | 4 | e0ccf18edbae09fc1068f1e923f1bc0d0ff44195 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.95e-05 | 194 | 54 | 4 | fc0504730ae576ff46ba0bc9f585c53ab78d914c | |
| ToppCell | Differ-Basal|World / shred by cell class for mouse tongue | 8.95e-05 | 194 | 54 | 4 | 851eff82c9f3d44c86e3e127a804bbd1fced6a7c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.13e-05 | 195 | 54 | 4 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 9.13e-05 | 195 | 54 | 4 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.13e-05 | 195 | 54 | 4 | bfaceb0601cf3855f38d6e1f482f01ad03ef11fe | |
| ToppCell | (3)_Chondrocytes-(34)_Chondro-progen|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.50e-05 | 197 | 54 | 4 | 012c49a57f9c2a3dfa988cd3882c8c6b7ef3a5ad | |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.50e-05 | 197 | 54 | 4 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.50e-05 | 197 | 54 | 4 | bd9d57e0c873f6526dca322f4dad8e6bd692586c | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 54 | 4 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.69e-05 | 198 | 54 | 4 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.69e-05 | 198 | 54 | 4 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 54 | 4 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS2|tumor_Lung / Location, Cell class and cell subclass | 9.88e-05 | 199 | 54 | 4 | 28ec59e01061287fb0892491790b316e2b93e232 | |
| ToppCell | Sigmoid-T_cell-Th17|T_cell / Region, Cell class and subclass | 9.88e-05 | 199 | 54 | 4 | 622f2ae4b1850b25f723a0385da49147dfec8285 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 9.88e-05 | 199 | 54 | 4 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| Computational | Neighborhood of EGFR | 1.12e-04 | 32 | 32 | 3 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 1.47e-04 | 35 | 32 | 3 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 2.54e-04 | 42 | 32 | 3 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 3.34e-04 | 46 | 32 | 3 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 4.02e-04 | 49 | 32 | 3 | GNF2_KISS1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.27e-04 | 50 | 32 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.27e-04 | 50 | 32 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_40_PDAC_RELATED | |
| Computational | Genes in the cancer module 11. | 8.72e-04 | 540 | 32 | 7 | MODULE_11 | |
| Drug | AC1L1IPV | 7.41e-12 | 43 | 53 | 7 | CID000004683 | |
| Drug | Rgd Peptide | 7.74e-08 | 239 | 53 | 8 | CID000104802 | |
| Drug | Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 6.18e-06 | 196 | 53 | 6 | 832_UP | |
| Drug | l 8 h | 7.91e-06 | 17 | 53 | 3 | CID000151041 | |
| Drug | TMPEG | 1.59e-05 | 3 | 53 | 2 | CID003081694 | |
| Drug | AC1NSPI9 | 3.18e-05 | 4 | 53 | 2 | CID005313629 | |
| Disease | cD177 antigen measurement | 2.58e-08 | 18 | 52 | 4 | EFO_0021866 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 1.01e-04 | 51 | 52 | 3 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | lung cancer (implicated_via_orthology) | 1.09e-04 | 9 | 52 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | cortical thickness | 1.28e-04 | 1113 | 52 | 9 | EFO_0004840 | |
| Disease | smoking status measurement, forced expiratory volume | 1.66e-04 | 11 | 52 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | Amelogenesis Imperfecta | 1.99e-04 | 12 | 52 | 2 | C0002452 | |
| Disease | mean arterial pressure | 2.39e-04 | 499 | 52 | 6 | EFO_0006340 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 3.60e-04 | 16 | 52 | 2 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 3.60e-04 | 16 | 52 | 2 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 3.60e-04 | 16 | 52 | 2 | cv:C1839071 | |
| Disease | Amelogenesis imperfecta | 4.07e-04 | 17 | 52 | 2 | cv:C0002452 | |
| Disease | neuroimaging measurement | 5.28e-04 | 1069 | 52 | 8 | EFO_0004346 | |
| Disease | alcohol use disorder measurement | 5.54e-04 | 214 | 52 | 4 | EFO_0009458 | |
| Disease | serum carcinoembryonic antigen measurement | 5.67e-04 | 20 | 52 | 2 | EFO_0005760 | |
| Disease | pulse pressure measurement | 6.63e-04 | 1392 | 52 | 9 | EFO_0005763 | |
| Disease | biological sex | 7.26e-04 | 230 | 52 | 4 | PATO_0000047 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 1.12e-03 | 28 | 52 | 2 | DOID:8466 (biomarker_via_orthology) | |
| Disease | Antihypertensive use measurement | 1.23e-03 | 265 | 52 | 4 | EFO_0009927 | |
| Disease | mood instability measurement | 1.51e-03 | 128 | 52 | 3 | EFO_0008475 | |
| Disease | tea consumption measurement | 1.54e-03 | 129 | 52 | 3 | EFO_0010091 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.62e-03 | 286 | 52 | 4 | EFO_0004346, EFO_0006930 | |
| Disease | bitter alcoholic beverage consumption measurement | 1.68e-03 | 133 | 52 | 3 | EFO_0010092 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTSFTVGQYFAAPWN | 336 | Q5U5X8 | |
| AWFQTPYTTFGQSPD | 411 | Q9Y6F8 | |
| KAWFQTPYTTFGQSP | 411 | Q9Y6F7 | |
| TSQQNVYNPSEGSTW | 681 | Q2M2I8 | |
| AASNPPAQYSWFVNG | 261 | P06731 | |
| AASNPPSQYSWSVNG | 261 | P31997 | |
| TSSSFFAAPNPYWNS | 441 | P11308 | |
| GSSNTFPVWFEYPVQ | 446 | Q9Y2F9 | |
| SPSYGSPEDTDSFWN | 231 | O00213 | |
| IYPSCFGNTPEWNSS | 511 | P78312 | |
| ATQWGSFYSPAQTAN | 1731 | Q9HCM3 | |
| NDPPATNSYSPWNLT | 136 | A0A2R8YFM6 | |
| SSTSSGEWYQNFQPP | 621 | P30203 | |
| WFLNGTATQTSTPSY | 56 | Q92637 | |
| VNGTGPPSNWYTAET | 701 | P43146 | |
| NSTNPSNWDFGSSFF | 86 | Q96T55 | |
| STPFVWGTTHYSDNN | 116 | Q8WW33 | |
| AASNPPAQYSWFING | 261 | P40199 | |
| VWSRNGGQASSSPNY | 361 | P15884 | |
| WEPNTTFSSTNFPNS | 531 | P98073 | |
| YWNGANSPYAAQPTS | 316 | P16278 | |
| SVTFSNSYGSQWSPD | 1106 | Q9HD67 | |
| PWLNQPTGFYASSSV | 1526 | Q8WWI1 | |
| ANPSQPPSDLGYTWN | 566 | Q07075 | |
| ISSSPIYTAWNGNFS | 491 | Q6IE36 | |
| GPGTWLDTSNVTYSN | 101 | Q7Z442 | |
| WFYNSGSNTPQQPDQ | 181 | Q9UQ26 | |
| NPPATDFTYAQNNTW | 2061 | Q5VYJ5 | |
| TYNATWTPQNISSPN | 3281 | O60494 | |
| SEQNFQWSIYLPSSP | 51 | O75054 | |
| SISSATQFGNVPWYS | 316 | P09958 | |
| WFLNGTATQTSTPSY | 56 | P12314 | |
| SASWQNSVSERPPYS | 226 | Q08050 | |
| WESSGQPENNYNTTP | 311 | P01860 | |
| PWSPDENFPSYNTAS | 721 | Q9NRM1 | |
| SSGTYWPVNSDQAVP | 91 | Q6ZRV2 | |
| SSLTYFWPKSNNSPE | 256 | Q9H207 | |
| AQSSPPWSYDQSYPS | 291 | Q13950 | |
| NWSPPVQSNETSNGY | 2441 | Q93008 | |
| WPNPTNANSIPYSSA | 221 | P81877 | |
| ASPQVTYAGPNTWFQ | 416 | Q00889 | |
| ADSNPPAQYSWTING | 356 | Q9UQ74 | |
| TESNPPAEYFWTING | 356 | Q00887 | |
| PNASSPFGFWSQEGQ | 356 | P08F94 | |
| ADSNPPAQYSWTING | 356 | Q13046 | |
| SGNDSFPQNGSSPWY | 136 | Q7Z7C7 | |
| NPNATPAQWASSQYG | 1576 | Q7KZ85 | |
| NPTSTQYTSSWGAQI | 321 | I1YAP6 | |
| QPAPWSQPAFYDSSE | 651 | Q9UMS6 | |
| PVSQESSWSQEYSFG | 151 | Q8IX01 | |
| WQPNLNSGATPTSYI | 581 | Q9Y6N7 | |
| SSQELNSSLNWPPYT | 1156 | Q8NDV7 | |
| GAWPYSASDNSFTNV | 1541 | Q9UPQ9 | |
| LWGYSSSPQPQTVAA | 241 | Q6UXF1 |